Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Apr 6, 2012

NEW YORK (GenomeWeb News) – Knome this week added some new faces to its executive team, naming Jay Therrien as senior VP and head of global sales, Charles Abdalian as chief financial officer, and Adam Rosenberg as senior VP and head of corporate development.

Therrien was VP of commercial operations and sequencing at Life Technologies, and also had spent five years in various sales leadership roles at Illumina.

Abdalian recently was senior VP and CFO of Molecular Insight Pharmaceuticals, and he was senior VP of finance and CFO at Coley Pharmaceutical.

Rosenberg previously was an adviser for emerging life sciences companies, co-founder of Clean Membranes, and CEO of Link Medicine.

The company also has appointed Hugh Reinhoff to serve on its scientific advisory board. Reinhoff is currently a managing director of Life Science Venture Partners, an adjunct scientist at the Children's Hospital Oakland Research Institute, and CEO of FerroKin BioSciences.


Pacific Biosciences said this week that Hugh Martin has resigned from its board of directors for personal reasons, effective immediately. Martin was previously the firm's president and CEO but resigned at the beginning of this year and was replaced by Michael Hunkapiller. He had led the company since 2004 and has been battling multiple myeloma, with which he was diagnosed in 2009.


GenMark Diagnostics has appointed Richard Slansky to be company CFO. Slansky has 25 years of experience as CFO at private and public companies, and he has held that position at Digirad over the past three years. He will succeed Paul Ross, who will leave GenMark after a transition period to pursue another opportunity.


The National Heart, Lung, and Blood Institute has named Gary Gibbons to be its new director. Gibbons is founder and current director of the Cardiovascular Research Institute and a professor and chairperson of the Department of Physiology at the Morehouse School of Medicine in Atlanta. Gibbons will take over the post this summer, and Acting Director Susan Shurin will resume her role as deputy director when he arrives.


Todd Johnson has resigned his position as executive VP of marketing, corporate development, and strategy at Accelrys, the company said in a filing with the Securities and Exchange Commission this week. Johnson has held various roles at the company since January 2009.


Molecular diagnostics company Veracyte has appointed Richard Kloos to be senior medical director. In the role, he will serve as a representative for the company's thyroid analysis product to the endocrinology community. Kloos formerly was a professor of endocrinology and metabolism and nuclear medicine at The Ohio State University and an attending physician at The OSU Comprehensive Cancer Center.


Danaher has named Angela Lalor to be senior VP of human resources. Lalor spent 22 years at 3M, where she was responsible for all aspects of the firm's global human resources strategy.


OvasScience has appointed Jeffrey Capello to serve on its board of directors. Capello is executive VP and CFO of Boston Scientific, and he formerly was senior VP and CFO for business development and a partner at PricewaterhouseCoopers.


BlueGnome has appointed Gary Harton to be its IVF business development manager for the Americas. Harton will be responsible for BlueGnome's 24sure product line, an array-based aneuploidy screening technology that is being used in a number of studies to improve in vitro fertilization success rates.

Harton joined BlueGnome from Reprogenetics, where he was the head of molecular genetics R&D. Prior to Reprogenetics, Harton held various roles at the Genetics & IVF Institute. He is currently the chair of the European Society of Human Reproduction & Embryology's Preimplantation Genetic Diagnosis Consortium's steering committee.


Activiomics announced this week that it has appointed Trevor Nicholls to its board as a non-executive chairman. Nicholls is CEO of CABI, a non-profit intergovernmental organization owned by 46 member countries, and also serves as non-executive chairman of Oxford Nanopore Technologies. Previously, he was chief commercial officer at Affymetrix.


Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.